Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs. Company website: www.scinai.com


Pharmaceutical

Scinai Immunotherapeutics

Amir Reichman

Dalit Fischer

Maxim Leykin

Gal Ron

Merav Kamensky

Elad Mark 

Joshua E. Phillipson

Uri Ben-Or

Tamar Ben-Yedidia

Dalit Weinstein Fischer

Leadership Team

Technical and Research Team

Executive

Corporate Administration Team

��

Teams at Scinai Immunotherapeutics

Leadership Team

Technical and Research Team

Executive

Corporate Administration Team

��������

Teams at Scinai Immunotherapeutics

Leadership Team

Technical and Research Team

Executive

Corporate Administration Team

��